Investing.com - Fresenius Medical Care ADR reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Fresenius Medical Care ADR announced earnings per share of $0.5451 on revenue of $5.15B. Analysts polled by Investing.com anticipated EPS of $0.5561 on revenue of $5.31B.
Fresenius Medical Care ADR shares are down 12% from the beginning of the year and are trading at $34.10 , down-from-52-week-high.They are under-performing the STOXX 600 which is up 20.17% from the start of the year.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by Danaher on Thursday, October 21, 2021, who reported EPS of $2.39 on revenue of $7.23B, compared to forecasts EPS of $2.15 on revenue of $7B.
Merck&Co had beat expectations on Thursday, October 28, 2021 with third quarter EPS of $1.75 on revenue of $13.15B, compared to forecast for EPS of $1.55 on revenue of $12.32B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar